Atrás
6
También listada como
PIAHY
OTC
Rango del Día
$1.55
$1.55
Rango de 52 Semanas
$0.78
$2.45
Volumen
100
Promedio 50D / 200D
$1.90
/
$1.62
Cierre Anterior
$1.76
Historial de Precios
Tendencias Financieras
Comparación con Pares
vs mediana del sector Healthcare (626 pares)
| Métrica | Acción | Mediana del Sector |
|---|---|---|
| P/E | 41.0 | 0.4 |
| P/B | 0.9 | 2.9 |
| ROE % | 1.0 | 3.8 |
| Net Margin % | 1.7 | 3.9 |
| Rev Growth 5Y % | -8.5 | 10.0 |
| D/E | 0.0 | 0.2 |
Puntos Clave
Revenue declined -8.52% annually over 5 years
ROE of 0.97% is below average
Debt/Equity of 0.01 — conservative balance sheet
Generating 65.09M in free cash flow
P/E of 41.02 — premium valuation
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 11.40%
Crecimiento
Revenue Growth (5Y)
-8.52%
Revenue (1Y)2.88%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Calidad
Return on Equity
0.97%
ROIC-1.84%
Net Margin1.69%
Op. Margin-1.85%
Seguridad
Debt / Equity
0.01
Current Ratio1.02
Interest Coverage-26.20
Valoración
P/E Ratio
41.02
P/B Ratio0.93
EV/EBITDAN/A
Dividend Yield1.54%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 2.88% | Revenue Growth (3Y) | -11.97% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | -8.52% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 4.81B | Net Income (TTM) | 81.43M |
| ROE | 0.97% | ROA | 0.49% |
| Gross Margin | 31.68% | Operating Margin | -1.85% |
| Net Margin | 1.69% | Free Cash Flow (TTM) | 65.09M |
| ROIC | -1.84% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.01 | Current Ratio | 1.02 |
| Interest Coverage | -26.20 | Dividend Yield | 1.54% |
| Valuation | |||
| P/E Ratio | 41.02 | P/B Ratio | 0.93 |
| P/S Ratio | 0.69 | PEG Ratio | -0.66 |
| EV/EBITDA | N/A | Dividend Yield | 1.54% |
| Market Cap | 3.34B | Enterprise Value | 1.34B |
Income Statement
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | 4.81B | 4.67B | 6.21B | 7.33B | 6.87B |
| Net Income | 81.43M | -322.59M | -636.06M | -1.54B | -948.48M |
| EPS (Diluted) | 0.08 | -0.30 | -0.59 | -1.39 | -0.92 |
| Gross Profit | 1.52B | 1.51B | 1.67B | 1.71B | 1.86B |
| Operating Income | -89.06M | -575.26M | -726.34M | -1.64B | -919.14M |
Balance Sheet
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Total Assets | 16.78B | 16.52B | 17.14B | 17.88B | 18.56B |
| Total Liabilities | 13.20B | 3.25B | 3.68B | 3.79B | 2.71B |
| Shareholders' Equity | 3.59B | 13.28B | 13.46B | 14.08B | 15.83B |
| Total Debt | 45.00M | 93.61M | 176.49M | 201.30M | 113.97M |
| Cash & Equivalents | 2.04B | 1.87B | 3.70B | 3.06B | 7.92B |
| Current Assets | 13.40B | 13.33B | 12.46B | 12.76B | 15.26B |
| Current Liabilities | 13.08B | 3.10B | 3.45B | 3.67B | 2.67B |
Puntuaciones de Estrategias
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
#805 of 820
Actividad Reciente
Entró
Deep Value Investing (Seth Klarman)
Mar 24, 2026